Azoles
-
Subject Areas on Research
- Antifungal serum concentration monitoring: an update.
- Antifungal treatment in pediatric patients.
- Azole antifungals: 35 years of invasive fungal infection management.
- Changing Epidemiology of Invasive Mold Infections in Patients Receiving Azole Prophylaxis.
- Comparative evaluation of Etest and sensititre yeastone panels against the Clinical and Laboratory Standards Institute M27-A2 reference broth microdilution method for testing Candida susceptibility to seven antifungal agents.
- Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy.
- Current options in antifungal pharmacotherapy.
- Executive Summary: Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.
- Fatty acid synthesis is essential for survival of Cryptococcus neoformans and a potential fungicidal target.
- Formation of azole-resistant Candida albicans by mutation of sterol 14-demethylase P450.
- Fungal CYP51 Inhibitors VT-1161 and VT-1129 Exhibit Strong In Vitro Activity against Candida glabrata and C. krusei Isolates Clinically Resistant to Azole and Echinocandin Antifungal Compounds.
- Hsp90 governs echinocandin resistance in the pathogenic yeast Candida albicans via calcineurin.
- Identification of a key lysine residue in heat shock protein 90 required for azole and echinocandin resistance in Aspergillus fumigatus.
- In vitro activity of calcineurin and heat shock protein 90 Inhibitors against Aspergillus fumigatus azole- and echinocandin-resistant strains.
- Management of drug and food interactions with azole antifungal agents in transplant recipients.
- Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.
- Review of newer antifungal and immunomodulatory strategies for invasive aspergillosis.
- Structural analyses of Candida albicans sterol 14α-demethylase complexed with azole drugs address the molecular basis of azole-mediated inhibition of fungal sterol biosynthesis.
- The Hsp90 co-chaperone Sgt1 governs Candida albicans morphogenesis and drug resistance.
- Treatment options for invasive fungal infections.
-
Keywords of People
- Juvvadi, Praveen Rao, Associate Professor in Pediatrics, Pediatrics, Infectious Diseases
- Sullivan, Daniel Carl, Professor Emeritus of Radiology, Radiology